Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
US Physical Therapy
USPH
$1.24B
| $3.71M | 0.01% |
30,549
-34,974
| -53% | -$3.77M |
|
|
FORG
1602
DELISTED
ForgeRock, Inc.
FORG
| $3.69M | 0.01% |
179,500
-94,800
| -35% | -$1.9M |
|
1603
Danaos Corp
DAC
$2.56B
| $3.68M | 0.01% |
55,100
-40,800
| -43% | -$2.46M |
|
1604
LifeVantage
LFVN
$81.9M
| $3.67M | 0.01% |
843,218
-3,100
| -0.4% | -$12.8K |
|
1605
Cintas
CTAS
$80.3B
| $3.66M | 0.01% |
29,472
-383,600
| -93% | -$45M |
|
1606
Lincoln Educational Services
LINC
$955M
| $3.64M | 0.01% |
540,478
+7,100
| +1% | +$44.8K |
|
1607
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.4B
| $3.63M | 0.01% |
54,500
+38,900
| +249% | +$2.47M |
|
|
MORF
1608
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $3.63M | 0.01% |
63,300
-57
| -0.1% | -$2.98K |
|
1609
iShares Core Dividend Growth ETF
DGRO
$43.9B
| $3.63M | 0.01% |
70,400
+47,700
| +210% | +$2.4M |
|
1610
Home Bancorp
HBCP
$569M
| $3.63M | 0.01% |
109,173
+500
| +0.5% | +$16.1K |
|
1611
NETGEAR
NTGR
$647M
| $3.61M | 0.01% |
254,937
+152,637
| +149% | +$2.3M |
|
1612
Global Water Resources
GWRS
$256M
| $3.6M | 0.01% |
283,847
+29,900
| +12% | +$353K |
|
1613
Fulgent Genetics
FLGT
$513M
| $3.59M | 0.01% |
96,954
+14,000
| +17% | +$488K |
|
1614
Voyager Therapeutics
VYGR
$198M
| $3.58M | 0.01% |
313,000
+180,700
| +137% | +$1.87M |
|
|
WSR
1615
DELISTED
Whitestone REIT
WSR
| $3.58M | 0.01% |
368,584
-176,600
| -32% | -$1.59M |
|
1616
Nomura Holdings
NMR
$29.2B
| $3.57M | 0.01% |
931,190
+583,200
| +168% | +$2.16M |
|
1617
Accel Entertainment
ACEL
$1.01B
| $3.56M | 0.01% |
337,500
+90,600
| +37% | +$851K |
|
1618
Columbus McKinnon
CMCO
$550M
| $3.56M | 0.01% |
87,585
+56,785
| +184% | +$2.1M |
|
1619
First Northwest Bancorp
FNWB
$108M
| $3.56M | 0.01% |
312,405
-4,501
| -1% | -$51.4K |
|
1620
Graham Holdings Company
GHC
$4.97B
| $3.54M | 0.01% |
6,200
-2,700
| -30% | -$1.56M |
|
1621
Bankwell Financial Group
BWFG
$542M
| $3.54M | 0.01% |
145,103
-25,884
| -15% | -$614K |
|
|
GOGL
1622
DELISTED
Golden Ocean Group
GOGL
| $3.54M | 0.01% |
468,669
-152,200
| -25% | -$1.27M |
|
1623
Immersion
IMMR
$248M
| $3.53M | 0.01% |
499,133
+232,233
| +87% | +$1.72M |
|
|
AMJ
1624
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $3.53M | 0.01% |
154,000
+90,800
| +144% | +$2.04M |
|
|
SMMF
1625
DELISTED
Summit Financial Group, Inc.
SMMF
| $3.53M | 0.01% |
170,735
-41,100
| -19% | -$808K |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.